YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF‐κB signalling pathways via inhibiting EPHB3 and TNFAIP3

por Chen, Yu, Wang, Yan‐Lan, Qiu, Kai, Cao, Yi‐Qiang, Zhang, Feng‐Jiang, Zhao, Hai‐Biao, Liu, Xian‐Zhi
Publicado 2022

Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma

por Li, Ke, Duan, Wen-chao, Zhao, Hai-biao, Wang, Li, Wang, Wei-wei, Zhan, Yun-bo, Sun, Tao, Zhang, Feng-jiang, Yu, Bin, Bai, Ya-hui, Wang, Yan-min, Ji, Yu-chen, Zhou, Jin-qiao, Liu, Xian-zhi, Zhang, Zhi-feng, Zhang, Zhen-yu
Publicado 2019

Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas

por Zhang, Zhen-Yu, Zhan, Yun-Bo, Zhang, Feng-Jiang, Yu, Bin, Ji, Yu-Chen, Zhou, Jin-Qiao, Bai, Ya-Hui, Wang, Yan-Min, Wang, Li, Jing, Yan, Duan, Wen-Chao, Sun, Chen, Sun, Tao, Zhao, Hai-Biao, Li, Ke, Wang, Wen-Qing, Li, Ruo-Yan, Sun, Hong-Wei, Zhai, Guang, Wang, Shu-Kai, Wei, Xin-Ting, Yang, Bo, Yan, Dong-Ming, Liu, Xian-Zhi, Wang, Wei-Wei
Publicado 2019